Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
NCOA6 Gene	NCIT_C20702	[This gene plays a role in the transcriptional activation of target genes.]
Keyhole Limpet Hemocyanin IgM Antibody Measurement	NCIT_C132373	[The determination of the amount of keyhole limpet hemocyanin IgM antibody in a biological sample.]
Kallikrein-2 Measurement	NCIT_C132374	[The determination of the amount of kallikrein-2 in a biological sample.]
Lymphotoxin Alpha Measurement	NCIT_C132375	[The determination of the amount of lymphotoxin alpha in a biological sample.]
Neutrophilic Toxic Change Assessment	NCIT_C132376	[The determination of any type of toxic change in the neutrophilic cells within a sample.]
Oncostatin M Measurement	NCIT_C132377	[The determination of the amount of oncostatin M in a biological sample.]
DDR1 Gene	NCIT_C20718	[This gene plays a role in extracellular matrix communication processes.]
Receptor Tyrosine Kinase Gene	NCIT_C20719	[Tyrosine kinase receptors (TRKs) are a family of genes encoding neurotrophin receptors that include trkA, trkB, and trkC, which are related to development, differentiation, and survival of neural crest-derived neurons and central cholinergic neurons in normal tissue. The genes encoding trkA, trkB, and trkC are designated NTRK1, NTRK2, and NTRK3 and map to chromosomes 1, 9, and 15, respectively. A member of the TRK gene family, trkE, encodes a non-neuronal receptor for nerve growth factor. (from OMIM 600408)]
Vascular Endothelial Growth Factor A Measurement	NCIT_C132389	[The determination of the amount of vascular endothelial growth factor A in a biological sample.]
AMPH Gene	NCIT_C20714	[This gene is involved in endocytosis and synaptic transmission.]
BPHL Gene	NCIT_C20717	[This gene is involved in prodrug activation.]
Drug Metabolism	NCIT_C26633	[A series of chemical modifications of a drug compound by enzymatic activity that make the substrate (drug) more water soluble to allow its clearance from the body. Drug metabolism occurs in two phases: Phase I (biotransformation) involves oxidation, hydroxylation reduction, and hydrolysis. Phase II (conjugation) involves synthesis and conjugation.]
Calculated Panel Reactive Antibody Measurement	NCIT_C132381	[The determination of the calculated panel reactive antibody (CPRA), which is based on the number/type of unacceptable HLA antigens to which an organ recipient has been sensitized, and which algorithmically estimates the level of sensitization in the recipient. The CPRA is computed from HLA antigen frequencies in a given donor population using both anti-HLA class I and class II antibody specificities; it also represents the percentage of actual organ donors that express one or more unacceptable HLA antigens to which a recipient may react adversely.]
SP1 Gene	NCIT_C20711	[This gene plays a role in transcriptional regulation and is involved in several signal transduction pathways.]
Circulating Prostate Tumor Cell Count	NCIT_C132382	[The determination of the amount of circulating prostate tumor cells present in a sample.]
Circulating Tumor Cell Count	NCIT_C96593	[The determination of the amount of circulating tumor cells present in a sample.]
MED24 Gene	NCIT_C20712	[This gene plays a role in the transcriptional activation of Sp1.]
Free Prostate Specific Antigen Measurement	NCIT_C132383	[The determination of the amount of free prostate specific antigen in a biological sample.]
Prostate Specific Antigen Measurement	NCIT_C17634	[The determination of the prostate specific antigen present in a sample.]
Autoantigen Gene	NCIT_C20713